The Valley Desk

NCT02573740 · Interventional trial

Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment

Overall registry status Terminated

Phase 1

Conditions Alzheimer's Disease, Mild Cognitive Impairment

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov